Affiliation:
1. , Baripada, Odisha , India
2. , Bhubaneswar, Odisha, India
Abstract
Tuberculosis is a chronic inflammatory, granulomatous bacterial infectious disease caused by Mycobacterium tuberculosis. About 10 million people worldwide are ill with MTB in 2018, 5.7 million are males, 3.2 million are females and 1.1 million are infants, 1.6 million died from the disease. This article includes epidemiology, classification, pathogenesis, diagnosis and treatment of Tuberculosis. It includes the drug profile of antitubercular agents such as isoniazid, pyrazinamide, ethambutol, rifampicin, paraminosalicylic acid, thiacetazone, ethionamide, kanamycin, amikacin. cycloserine, viomycin, morphazinamide and some newer drugs such as ofloxacin, ciprofloxacin, clarithromycin and rifabutin. It contains analytical detection methods of antitubercular agents by HPLC.
Publisher
IP Innovative Publication Pvt Ltd
Reference68 articles.
1. Shang S, Siddiqui S, Bian Y, Zhao J, Wang CR, Nonclassical MHC Ib-restricted CD8+ T cells recognize mycobacterium tuberculosis-derived protein antigens and contribute to protection against infection..PLoS pathogens 2016;12(6):e1005688
2. Barberis I, Bragazzi N L, Galluzzo L, Martini M, .The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus. Journal of preventive medicine and hygiene 2017;58:9-9
3. World Health Organization.World Health Organization. World malaria report.
4. Floyd K, Pantoja A, Financial resources required for tuberculosis control to achieve global targets set for 2015.Bulletin of the World Health Organization 2008;86:568-76
5. Kay A, Barry P M, Annambhotla P, Greene C, Cilnis M, Chin-Hong P, Arger N, Mcnitt L, Neidlinger N, Shah N, Basavaraju S V, Solid Organ Transplant-Transmitted Tuberculosis Linked to a Community Outbreak-California.MMWR. Morbidity and mortality weekly report 2015;66:801-801